Wild-type C57BL6J Mice Research Articles

A Novel Mouse Model of Physical Inactivity to Study the Role of Mitochondria in Chronic Kidney Disease

Chronic kidney disease (CKD) is a progressive disorder marked by a decline in kidney function. It is thought that a decline in mitochondrial function likely contributes to the pathogenesis of CKD, but the detailed mechanisms remain unclear. This gap in knowledge is contributed by a lack of a murine CKD model that does not rely on injury, toxin, or gene deletion to induce reduced kidney function. In humans, obesity and sedentary behavior strongly contribute to the development of CKD. The aim of the study was to employ small mouse cage (SMC) housing, a novel mouse physical inactivity model that was recently developed in our lab, and test whether it can be used to reliably induce CKD in mice. Wildtype C57BL6J mice were given standard chow or Western high-fat diet (HFD) with or without SMC intervention for 24 weeks to examine the effects of HFD and SMC on glomerular filtration rate (GFR) and respiration on isolated mitochondria from kidney cortex. Although the GFR values of the HFD+SMC group trended higher than other groups, the kidney function was still considered to be normal. Neither HFD nor HFD+SMC group had developed CKD, but mitochondrial respiration of SMC+HFD (1512.64 ± 77.86 pmol·sec−1·mgprotein−1) was significantly greater than that of the HFD-only group (1307.82 ± 79.08 pmol·sec−1·mgprotein−1, p = 0.0017) or the standard chow group (1104.69 ±143.12 pmol·sec−1·mgprotein−1, p = 0.0314. One-way ANOVA followed by Tukey’s test for multiple comparisons). Increased mitochondrial respiration may suggest a hyperfiltration-induced stress response, as commonly observed in the early stages of CKD in humans, and/or an increase in respiration to compensate for reduced effciency of oxidative phosphorylation. We interpret these data to mean that HFD and HFD+SMC are beginning to show adaptations that are in an early phase of CKD development. However, this model requires further optimization to yield the CKD phenotype. Therefore, we intend to further adapt the intervention to induce symptomatic CKD. We envision that developing preclinical models of CKD will help better elucidate its molecular mechanism and identify therapeutic targets for treating CKD in human patients. DK107397, DK127979. This is the full abstract presented at the American Physiology Summit 2024 meeting and is only available in HTML format. There are no additional versions or additional content available for this abstract. Physiology was not involved in the peer review process.

Sex and dose-dependent antinociceptive effects of the JNK (c-Jun N-terminal kinase) inhibitor SU 3327 are mediated by CB2 receptors in female, and CB1/CB2 receptors in male mice in an inflammatory pain model

Activation of c-Jun N-terminal kinases (JNKs) has been implicated in the development and persistence of inflammatory and neuropathic pain in animal models. Moreover, JNKs have been involved in the maintenance of chronic pain, as well as development of tolerance to antinociceptive agents in the opioid and cannabinoid class of compounds. In this study, we evaluated the antinociceptive effects of the JNK inhibitor SU 3327 (0.3-30mg/kg) in the formalin pain model with an emphasis on the sex-specific actions of this compound. In wild-type C57BL6J mice, SU 3327 produced strong antinociceptive effects in the formalin pain model which were mediated by CB2 receptors in females, and both CB1 and CB2 receptors in males. SU 3327 at a dose of 10mg/kg produced antinociception, hypothermia, motor impairment, and hypolocomotion to a similar extent in both males and females. The antinociceptive effects of SU 3327 were more potent in males at lower doses (1 and 3mg/kg), while females were more sensitive to the hypothermic, and motor-suppression effects at lower (3mg/kg) doses versus males. Analysis of spinal cords, using qPCR following SU 3327 administration in the formalin test, revealed changes in cannabinoid, tolerance and inflammatory markers in females only, and only in the high (10-30mg/kg) dose conditions. Indeed, females showed an increase in mRNA levels of cannabinoid (CB2), but a decrease in tolerance (β-arrestin 1) and inflammatory (TNF-α, IL-1β, IL-6)-associated markers. The differences between males and females, in this study, support sex as an important factor in nociception and antinociceptive responses mediated by JNK and the endocannabinoid system.

Single transient intraocular pressure elevations cause prolonged retinal ganglion cell dysfunction and retinal capillary abnormalities in mice

Transient intraocular pressure (IOP) elevations are likely to occur in certain forms of glaucoma and after intravitreal injections to treat various retinal diseases. However, the impact of these transient IOP elevations on the physiology of individual retinal ganglion cells (RGCs) is unknown. In this report, we explore how transient IOP elevations in mice affect RGC physiology, RGC anatomy, and retinal arteriole and capillary structure. Transient IOP elevation was induced in 12-week old wild type C57BL6J mice by injecting sodium hyaluronate into the anterior chamber. IOP was measured immediately after the injection and again 1 and 7 days later. Average peak IOP after injection was ~50mmHg and subsequent IOPs returned to normal. RGC physiology was assessed with a multielectrode array (MEA) by calculating a spike triggered average (STA) at the same time points. RGC counts and retinal vascular structure were assessed 14 days after injection with immunohistochemistry to label RGCs and blood vessels. Transient IOP elevation caused a marked reduction of scotopic STA presence and delayed center and surround STA peak times that did not recover. Transient IOP elevation also caused a reduced photopic receptive field size and spontaneous firing rate, both of which showed some recovery with time. Transient IOP elevation also induced vascular remodeling: the number of capillary branches was decreased within the superficial and intermediate vascular plexi. RGC counts, retinal arteriole diameter, and deep capillary plexus branching were unaffected. These previously unappreciated findings suggest that transient IOP elevation may cause unrecognized and potentially long-term pathology to RGCs and associated neurovascular units which should be accounted for in clinical practice.

Stimulus-Driven Retinal Intrinsic Signal Optical Imaging in Mouse Demonstrates a Dominant Rod-Driven Component.

PurposeThe primary hypotheses tested are that (1) there exist stimulus-driven intrinsic optical signals in the mouse retina similar to those previously observed in other species, and (2) these optical signals require an intact rod photoreceptor phototransduction cascade.MethodsWe used 38 wild-type C57BL6J mice and 18 genetic knockout Gnat1−/− mice to study the light-evoked retinal intrinsic response. A custom mouse fundus camera delivered visual stimuli and collected mouse retinal imaging data of changes in retinal reflectance for further analysis. The retina was stimulated in the high-mesopic range with a 505-nm light-emitting diode while also being illuminated with 780-nm near-infrared light.ResultsWild-type C57BL6J mice yielded retinal imaging signals that typically showed a stimulus-driven decrease in retinal reflectance of ∼0.1%, with a time course of several seconds. The signals exhibit spatial specificity in the retina. Overall, the mouse imaging signals are similar in sign and time course to those reported in other mammalian species but are of lower amplitude. In contrast, functional retinal imaging of Gnat1−/− mice that lack a functional rod transducin yielded no such stimulus-driven signals.ConclusionsPrevious studies have not shown which pathway component is essential for the generation of these imaged signals. The absence of the intrinsic signal responses in Gnat1−/− knockout mice indicates that a functional rod transducin is likely to be necessary for generating the retinal intrinsic signals. These studies, to the best of our knowledge, demonstrate for the first time in vivo mouse retinal functional imaging signals similar to those previously shown in other mammalian species.

Memory and Learning Deficits Are Associated With Ca2+ Dyshomeostasis in Normal Aging.

Neuronal intracellular Ca2+ homeostasis is critical to the normal physiological functions of neurons and neuronal Ca2+ dyshomeostasis has been associated with the age-related decline of cognitive functions. Accumulated evidence indicates that the underlying mechanism for this is that abnormal intracellular Ca2+ levels stimulate the dysregulation of intracellular signaling, which subsequently induces neuronal cell death. We examined intracellular Ca2+ homeostasis in cortical (in vivo) and hippocampal (in vitro) neurons from young (3-months), middle-age (12-months), and aged (24-months) wild type C57BL6J mice. We found a progressive age-related elevation of intracellular resting calcium ([Ca2+]r) in cortical (in vivo) and hippocampal (in vitro) neurons associated with increased hippocampal neuronal calpain activity and reduced cell viability. In vitro, removal of extracellular Ca2+ or treatment with SAR7334 or dantrolene reduced [Ca2+]r in all age groups and dantrolene treatment lowered calpain activity and increased cell viability. In vivo, both middle-aged and aged mice showed cognitive deficits compared to young mice, which improved after dantrolene treatment. These findings support the hypothesis that intracellular Ca2+ dyshomeostasis is a major mechanism underlying the cognitive deficits seen in both normal aging and degenerative neurologic diseases.

SAT-041 Bioinformatic Analysis of Human Cutaneous Melanomas Identifies Increased Mortality and Genetic Alterations in GH-responsive Tumors

The impact of growth hormone (GH) on systemic glucose, growth and the myriad of downstream targets indicate the potential to enhance the progression of cancers. There is, however, continued debate as to GH’s impact on cancer with varied effects across subjects and cancer types. To bridge this gap in fundamental understanding, 16 human cancer types were selected and the RNA expression data for all matching samples (primary or metastatic) were queried in The Cancer Genome Atlas (TCGA). Each cancer type was stratified into GH-responsive [GH receptor (R) expression in the top quartile of each cancer type] and baseline (the remaining 75% of samples). Patients with GH-responsive cutaneous melanomas had a significant reduction in post-diagnosis lifespan (log-rank test, P = 0.0073). To explore the deleterious effects of GH in melanoma progression, we developed a novel tool, gdc-file-matcher (https://github.com/pxslip/gdc-file-matcher), to extract dataset metadata. Using the extensive metadata available in TCGA, we identified a significant negative correlation (Pr(>|t|) = 0.021) between GHR expression and post-diagnosis lifespan in male melanoma patients who died within 1 year of diagnosis that drove the reduction in lifespan. The same trend, though not significant, was also observed in female melanoma patients. To validate the stratification approach, differential expression profiles were generated using a generalized linear model in EdgeR. The expression profiles were validated against expression levels of adiponectin, multiple ABC transporters, and metastatic markers in implanted B16-F10 melanomas in wild-type C57BL6J mice and transgenic bGH mice. The expression profiles of the implanted in vivo melanoma samples validated the stratification approach as indicative of GH action in human melanomas. To understand the molecular mechanisms resulting in increased mortality rates of GH-responsive tumors, the differentially expressed genes were investigated. The gene expression profiles showed clear evidence for a greater metastatic potential in GH-responsive tumors. In addition, upregulated genes showed an increased potential for angiogenesis and drug resistance along with a downregulation of DNA repair genes, P53 signaling cascades and other protective pathways. Thus, we demonstrate induced melanomas in the C57BL6J background are a reliable mouse model for translational research in GH-related cancer and are likely able to be expanded as a model for additional melanoma therapy research. Most critically, the survival and gene expression data from this in vivo validated informatic analysis demonstrate a clear role for Pegvisomant or alternate forms of GH modulation in the treatment of GH-responsive melanomas.

Traumatic Brain Injury by Weight-Drop Method Causes Transient Amyloid-β Deposition and Acute Cognitive Deficits in Mice.

There has been growing awareness of the correlation between an episode of traumatic brain injury (TBI) and the development of Alzheimer's disease (AD) later in life. It has been reported that TBI accelerated amyloid-β (Aβ) pathology and cognitive decline in the several lines of AD model mice. However, the short-term and long-term effects of TBI by the weight-drop method on amyloid-β pathology and cognitive performance are unclear in wild-type (WT) mice. Hence, we examined AD-related histopathological changes and cognitive impairment after TBI in wild-type C57BL6J mice. Five- to seven-month-old WT mice were subjected to either TBI by the weight-drop method or a sham treatment. Seven days after TBI, the WT mice exhibited significantly lower spatial learning than the sham-treated WT mice. However, 28 days after TBI, the cognitive impairment in the TBI-treated WT mice recovered. Correspondingly, while significant amyloid-β (Aβ) plaques and amyloid precursor protein (APP) accumulation were observed in the TBI-treated mouse hippocampus 7 days after TBI, the Aβ deposition was no longer apparent 28 days after TBI. Thus, TBI induced transient amyloid-β deposition and acute cognitive impairments in the WT mice. The present study suggests that the TBI could be a risk factor for acute cognitive impairment even when genetic and hereditary predispositions are not involved. The system might be useful for evaluating and developing a pharmacological treatment for the acute cognitive deficits.

Consequences of early postnatal lipopolysaccharide exposure on developing lungs in mice.

Bronchopulmonary dysplasia (BPD) is a chronic lung disease of infants that is characterized by interrupted lung development. Postnatal sepsis causes BPD, yet the contributory mechanisms are unclear. To address this gap, studies have used lipopolysaccharide (LPS) during the alveolar phase of lung development. However, the lungs of infants who develop BPD are still in the saccular phase of development, and the effects of LPS during this phase are poorly characterized. We hypothesized that chronic LPS exposure during the saccular phase disrupts lung development by mechanisms that promote inflammation and prevent optimal lung development and repair. Wild-type C57BL6J mice were intraperitoneally administered 3, 6, or 10 mg/kg of LPS or a vehicle once daily on postnatal days (PNDs) 3-5. The lungs were collected for proteomic and genomic analyses and flow cytometric detection on PND6. The impact of LPS on lung development, cell proliferation, and apoptosis was determined on PND7. Finally, we determined differences in the LPS effects between the saccular and alveolar lungs. LPS decreased the survival and growth rate and lung development in a dose-dependent manner. These effects were associated with a decreased expression of proteins regulating cell proliferation and differentiation and increased expression of those mediating inflammation. While the lung macrophage population of LPS-treated mice increased, the T-regulatory cell population decreased. Furthermore, LPS-induced inflammatory and apoptotic response and interruption of cell proliferation and alveolarization was greater in alveolar than in saccular lungs. Collectively, the data support our hypothesis and reveal several potential therapeutic targets for sepsis-mediated BPD in infants.

Lung omics signatures in a bronchopulmonary dysplasia and pulmonary hypertension-like murine model.

Bronchopulmonary dysplasia (BPD), the most common chronic lung disease in infants, is associated with long-term morbidities, including pulmonary hypertension (PH). Importantly, hyperoxia causes BPD and PH; however, the underlying mechanisms remain unclear. Herein, we performed high-throughput transcriptomic and proteomic studies using a clinically relevant murine model of BPD with PH. Neonatal wild-type C57BL6J mice were exposed to 21% oxygen (normoxia) or 70% oxygen (hyperoxia) during postnatal days (PNDs) 1-7. Lung tissues were collected for proteomic and genomic analyses on PND 7, and selected genes and proteins were validated by real-time quantitative PCR and immunoblotting analysis, respectively. Hyperoxia exposure dysregulated the expression of 344 genes and 21 proteins. Interestingly, hyperoxia downregulated genes involved in neuronal development and maturation in lung tissues. Gene set enrichment and gene ontology analyses identified apoptosis, oxidoreductase activity, plasma membrane integrity, organ development, angiogenesis, cell proliferation, and mitophagy as the predominant processes affected by hyperoxia. Furthermore, selected deregulated proteins strongly correlated with the expression of specific genes. Collectively, our results identified several potential therapeutic targets for hyperoxia-mediated BPD and PH in infants.

Loss of Function of P2X7 Receptor Scavenger Activity in Aging Mice: A Novel Model for Investigating the Early Pathogenesis of Age-Related Macular Degeneration

Age-related macular degeneration (AMD) is a leading cause of irreversible, severe vision loss in Western countries. Recently, we identified a novel pathway involving P2X7 receptor scavenger function expressed on ocular immune cells as a risk factor for advanced AMD. In this study, we investigate the effect of loss of P2X7 receptor function on retinal structure and function during aging. P2X7-null and wild-type C57bl6J mice were investigated at 4, 12, and 18 months of age for macrophage phagocytosis activity, ocular histological changes, and retinal function. Phagocytosis activity of blood-borne macrophages decreased with age at 18 months in the wild-type mouse. Lack of P2X7 receptor function reduced phagocytosis at all ages compared to wild-type mice. At 12 months of age, P2X7-null mice had thickening of Bruchs membrane and retinal pigment epithelium dysfunction. By 18 months of age, P2X7-null mice displayed phenotypic characteristics consistent with early AMD, including Bruchs membrane thickening, retinal pigment epithelium cell loss, retinal functional deficits, and signs of subretinal inflammation. Our present study shows that loss of function of the P2X7 receptor in mice induces retinal changes representing characteristics of early AMD, providing a valuable model for investigating the role of scavenger receptor function and the immune system in the development of this age-related disease.

Inactivation of the immune receptor CD40 attenuates the development of cardiac hypertrophy in angiotensin-II induced hypertensive heart disease

Emerging evidence indicates that inflammatory activation is a crucial pathway in disease progression during HF. The co-stimulatory dyad CD40-CD40L is involved in pro-inflammatory activation of a wide range of immune and non-immune cells and plasma levels of soluble CD40L in HF patients are raised. Here we investigated whether CD40-CD40L interactions attenuate cardiac hypertrophy in hypertensive heart disease. CD40 knockout and wild type C57Bl6-J mice were treated with angiotensin II (AngII, 2.5 mg/kg/day) for 4 weeks. AngII-induced hypertension led to a significant increase in cardiac mass in Wt mice (+31%, P<0.01), but not in CD40 knockout mice (+10%, N.S.). Comparable changes were observed in diastolic wall thickness (echocardiography) and cardiomyocyte cross sectional area. To determine which CD40-TRAF interactions were involved, the effect of mutations in the intracellular TRAF binding domains of CD40 was investigated. Relative to mice with intact downstream CD40 signaling, disruption of TRAF2/3/5, TRAF6 or both binding sites was associated with reduced cardiac hypertrophy (cardiac mass -24% for CD40-TΔ2, -28% for CD40-TΔ6 and -26% in CD40-TΔ2/6; p<0.05). Reduced hypertrophy was not associated with a decline in immune cell infiltration (CD45+ cells) or collagen content. Although the exact mechanism remains to be elucidated the present findings indicate a role for the CD40 receptor in the development of cardiac hypertrophy.

ENHANCED SUPEROXIDE ACTIVITY INDUCES SALT SENTSITIVITY IN ENDOGENOUS NITRIC OXIDE SYNTHASE KNOCKOUT MICE.

Nitric oxide (NO) synthase inhibition enhances superoxide (O2−) activity. The present study was conducted to examine the hypothesis that salt sensitivity is induced by superoxide (O2−) activity that is enhanced due to a deficiency in endogenous nitric oxide (NO) production. Male knockout (KO) mice lacking the gene for endothelial NO synthase and their genetic background wild-type C57BL6J mice (WT) were fed a diet containing either normal salt (NS, 0.4% NaCl) or high salt (HS, 4% NaCl) and treated with or without a O2− scavenger, tempol (400 mg/L), in drinking water for 2 weeks. Systolic blood pressure (SBP) was measured by tail-cuff plethysmography and urine collection was performed in metabolic cages on every third day during the 2-week experimental period. Urinary 8-isoprostane concentration (a marker for oxidative stress) was measured by ELISA kit (Cayman). Baseline SBP values in KO groups were significantly higher compared with WT groups (138 ± 5 vs 116 ± 4 mm Hg). At the end of the 2-week period, there was no significant difference in SBP between the tempol-treated and untreated WT groups with NS intake. However, SBP was significantly lower in tempol-treated KO mice compared with untreated KO mice fed on NS diets (131 ± 2 vs 142 ± 3 mm Hg). HS intake had no effect on SBP in untreated and treated WT groups; however, SBP was significantly increased in KO with HS intake (154 ± 4 mm Hg) over the 2-week period. Tempol significantly attenuated the effect of HS on SBP in the KO group (139 ± 2 mm Hg). There were no differences in baseline urinary 8-isoprostane excretion (UISOV) between WT and KO mice. However, at the end of 2 weeks, compared with WT and KO with NS intake (2.2 ± 0.1 and 2.4 ± 0.3 ng/d, respectively), UISOV was increased in both WT and KO groups with HS intake (2.9 ± 0.3 and 3.6 ± 0.2 ng/d, respectively), the increase in UISOV being greater in KO compared with WT. Tempol attenuated UISOV in both WT and KO with HS intake (2.5 ± 0.1 and 2.9 ± 0.2 ng/d). These data suggest that, in the condition of eNOS enzyme deficiency, dietary high-salt intake induces enhanced O2− activity that contributes to the development of salt-sensitive hypertension.